日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Anti-PD-1 antibody combined with P-GEMOX chemotherapy versus P-GEMOX chemotherapy with or without autologous stem-cell transplantation for previously untreated advanced natural killer/T cell lymphoma: a retrospective cohort study

抗PD-1抗体联合P-GEMOX化疗与P-GEMOX化疗联合或不联合自体干细胞移植治疗既往未接受治疗的晚期自然杀伤/T细胞淋巴瘤：一项回顾性队列研究

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-026-01459-1
Zou, Qihua; Cao, Yi; Wang, Liang; Li, Wuping; Yin, Qingsong; Wu, Yudan; Jing, Hongmei; Peng, Zhigang; Sun, Xiuhua; Rao, Jun; Chen, Ying; Zhang, Hongyu; Zeng, Dongfeng; Li, Bingzong; Zhao, Ying; Zhang, Xudong; Zhang, Yuchen; Gao, Yan; Bai, Bing; Xia, Yi; Fang, Yu; Chen, Zouxiang; Nie, Man; Fang, Xiaojie; Bai, Shenrui; Huang, Huiqiang; Cai, Qingqing; Cai, Jun
发育与干细胞
T细胞
淋巴瘤
T细胞
干细胞
细胞生物学
PD-1
免疫/内分泌
发表日期：2026
文献求助 收藏

A revised staging system for natural killer/T cell lymphoma incorporating skull base invasion and nasal/non-nasal subtype distinction

修订后的自然杀伤/T细胞淋巴瘤分期系统，纳入了颅底侵犯和鼻/非鼻亚型区分。

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102617
Cao, Yi; Zhang, Yuchen; Wang, Liang; Song, Yongping; Qi, Shunan; Cai, Peiqiang; Tao, Rong; Li, Zhihua; Shuang, Yuerong; Yin, Qingsong; Peng, Zhigang; Zhong, Liye; Sun, Xiuhua; Zhang, Hongyu; Zhao, Ying; Jing, Hongmei; Li, Bingzong; Zou, Qihua; Huang, Huiqiang; Gao, Yan; Xia, Yi; Nie, Man; Fang, Xiaojie; Gao, Xinna; Bai, Shenrui; Cai, Jun; Cai, Qingqing
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Epigenetic mechanisms and steroid-resistant nephrotic syndrome: The future potential for SRNS diagnosis

表观遗传机制与激素抵抗性肾病综合征：SRNS诊断的未来潜力

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2026.114973
Zhu, Yiying; Wang, Yinfeng; Haider, Cuello Garcia; Cao, Changling; Abdelhak, Ouzaouit; Fu, Yutong; Huang, Huiqiang; Jiang, Tingya; Zhou, Yang; Zhang, Xiaoge; Wu, Yu
表观遗传
免疫/内分泌
发表日期：2026
文献求助 收藏

High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study

高剂量甲氨蝶呤、伊布替尼和替莫唑胺治疗新诊断的原发性中枢神经系统淋巴瘤：一项多中心、前瞻性 II 期研究

期刊:Blood Cancer Discovery
影响因子:11.5
doi:10.1158/2643-3230.BCD-24-0156
Gao, Yan; Ping, Liqin; Shan, Changguo; Huang, He; Li, Zhiming; Zhou, Hui; Lai, Mingyao; Cai, Linbo; Bai, Bing; Huang, Cheng; Chen, Haoqing; Hong, Xiaoyu; Wang, Xiaoxiao; Huang, Huiqiang
淋巴瘤
神经科学
发表日期：2025
文献求助 收藏

Whole-genome sequencing reveals three follicular lymphoma subtypes with distinct cell of origin and patient outcomes

全基因组测序揭示了三种滤泡性淋巴瘤亚型，它们具有不同的细胞起源和患者预后。

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102278
Ren, Weicheng; Yang, Mingyu; Wang, Xianhuo; Nie, Man; Huang, Yuhua; Wan, Hui; Liu, Dongbing; Li, Xiaobo; Ye, Xiaofei; Meng, Bin; Jiang, Wenqi; Huang, Huiqiang; Li, Zhiming; Zhang, Huilai; Wu, Kui; Pan-Hammarström, Qiang
细胞生物学
淋巴瘤
发表日期：2025
文献求助 收藏

Heat shock factor 1 promotes proliferation and chemoresistance in diffuse large B-cell lymphoma by enhancing the cell cycle and DNA repair

热休克因子1通过增强细胞周期和DNA修复，促进弥漫性大B细胞淋巴瘤的增殖和化疗耐药性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07843-2
Fang, Yu; Cheng, Liang; Huang, Ming; Cao, Yi; Zou, Qihua; Cai, Jun; Zhang, Yuchen; Xia, Yi; Huang, Huiqiang; Chen, Xu; Cai, Qingqing
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Optimized multiplex PCR-NGS for comprehensive HLA genotyping in Chinese populations: resolving ambiguities at high resolution

针对中国人群HLA基因分型的优化多重PCR-NGS：高分辨率解析歧义

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1551173
Haider, Cuello Garcia; Sun, Binbin; Wang, Yinfeng; Zhang, Zhoufan; Cao, Changling; Zhu, Yiying; Abdelhak, Ouzaouit; Huang, Huiqiang; Liu, Haitao; Jiang, Tingya; Dong, Xueping; Zhou, Yang; Wu, Yu
发表日期：2025
文献求助 收藏

Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial

脂质体米托蒽醌单药治疗复发或难治性成熟T细胞和自然杀伤细胞肿瘤患者：一项II期、多中心、开放标签、单臂试验

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.35672
Gao, Yan; Huang, Yunhong; Zhang, Qingyuan; Yang, Haiyan; Li, Yufu; Li, Yan; Zhou, Min; Yang, Runxiang; Xu, Bing; Liu, Lihong; Yang, Yu; Peng, Zhigang; Yu, Ding; Zhou, Hui; Zhang, Rongyan; Zhang, Huilai; Qi, Junyuan; Xi, Yaming; Xing, Xiaojing; Wang, Zhao; Jing, Hongmei; Shuang, Yuerong; Zhang, Xiaohong; Ma, Liping; Jin, Hongyan; Lin, Li'e; Li, Chunlei; Xue, Jianfei; Liu, Yanping; Yuan, Jing; Huang, Huiqiang
肿瘤
T细胞
肿瘤免疫
T细胞
自然杀伤细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Improved efficacy of concurrent anti-PD1 antibody plus AVD versus ABVD in patients with newly diagnosed early unfavorable and advanced stage classic Hodgkin lymphoma: a retrospective matched cohort study

在初诊早期预后不良和晚期经典型霍奇金淋巴瘤患者中，同时使用抗PD-1抗体联合AVD方案较ABVD方案疗效更佳：一项回顾性匹配队列研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04041-z
Wu, Mengqiu; Sun, Peng; Zhao, Baitian; Yang, Hang; Xia, Yi; Nie, Man; Cai, Qingqing; Huang, Huiqiang; Huang, He; Xia, Zhongjun; Wang, Yu; Li, Zhiming; Liu, Panpan
淋巴瘤
PD-1
发表日期：2025
文献求助 收藏

Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial

皮托布替尼治疗中国复发或难治性B细胞恶性肿瘤患者：一项单臂、开放标签、II期、多中心试验

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35339
Liu, Yanyan; Lin, Ningjing; Yi, Shuhua; Huang, Huiqiang; Guo, Ye; Zhang, Qingyuan; Yang, Haiyan; Zhang, Huilai; Zhang, Liling; Feng, Ru; Qian, Yijiao; Zhu, Jiankun; Song, Yuqin; Zhu, Jun
B细胞
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏